View more in
Science

Phase 3 Trial Evaluating Lisocabtagene Maraleucel in Second-line Relapsed or Refractory Large B-cell Lymphoma Shows Positive Topline Results

pharmacytimes.com
 2021-06-18

Cover picture for the articlePositive topline results have been published from a phase 3 trial assessing the CD-19 directed CAR T cell therapy lisocabtagene maraleucel as a second-line treatment in adults with relapsed or refractory LBCL. Positive topline results have been published from the TRANSFORM phase 3 trial assessing the CD-19 directed chimeric antigen...

www.pharmacytimes.com

Comments / 0

Comments / 0